Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2026)

Adaptive Biotechnologies has disclosed Change in Acquisitions & Divestments across 9 years of filings, most recently posting $40.4 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments fell 26.67% year-over-year to $40.4 million; the TTM figure through Jun 2026 stood at $179.2 million (down 33.25% YoY), while the FY2025 annual figure was $222.6 million, down 31.65% from the prior year.
• Change in Acquisitions & Divestments came in at $40.4 million for Q2 2026 at Adaptive Biotechnologies, down from $48.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $155.0 million in Q1 2023 to a low of $35.0 million in Q2 2022.
• Average Change in Acquisitions & Divestments over 5 years is $83.6 million, with a median of $73.8 million recorded in 2022.
• Year-over-year, Change in Acquisitions & Divestments plunged 75.78% in 2022 and jumped 301.15% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $70.0 million in 2022, then soared by 80.63% to $126.5 million in 2023, then plunged by 47.04% to $67.0 million in 2024, then plunged by 41.62% to $39.1 million in 2025, then advanced by 3.37% to $40.4 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $40.4 million in Q2 2026, $48.8 million in Q1 2026, and $39.1 million in Q4 2025.